NASDAQ · MTEX

Mannatech Inc.

$4.50 -$0.16 (-3.43%) 1D Market open

Key Metrics

$8.99M
Market cap
P/E · TTM
$106.39M
Revenue · TTM
−$12.73M
Net income
EPS · TTM $-6.70
Dividend yield
Free cash flow −$1.46M
Beta · 1Y 0.42
EBITDA · TTM $1.29M
Gross margin 75.3%

The Story So Far

LAST 6 MONTHS PRIMARY SOURCES ONLY
  • Jul 16
    Money rotated out of high-beta cohorts market-wide.

    High-beta names lagged the blue-chips by 18.6 points over ten sessions around this date. Stocks in that cohort weren't falling alone — they fell together.

    RECEIPT: ROTATION GAUGE, LIVE
  • May 26
    The stock moved +26.5% in a single session.

    Sessions this size usually pair with a chapter above or below — a filing, a headline, or the whole cohort moving together.

    RECEIPT: DAILY BAR, May 26
  • May 20
    From its Feb 2 high, the share price fell 48%.

    Peak close $7.65 on Feb 2; trough close $3.95 on May 20. The drawdown is the fact — the chapters around it are the context.

    RECEIPT: PRICE SERIES, PEAK-TO-TROUGH -48%
  • May 8
    The stock moved +22.1% in a single session.

    Sessions this size usually pair with a chapter above or below — a filing, a headline, or the whole cohort moving together.

    RECEIPT: DAILY BAR, May 8

The story updates itself as events post · The wolf reports; you decide

Snapshot

Market cap$8.99M
Enterprise value$4.73M
Shares outstanding1.9M
52-wk range$3.80 – $12.45
Avg volume · 20D9.4K
Net cash $4.26M
Book value / share$-2.92
IndustryMedicinal Chemicals & Botanical Products
ExchangeNASDAQ
About Mannatech Inc.
IPO dateFeb 16, 1999
Employees170

Mannatech Inc is a wellness solution provider. The company develops and sells nutritional supplements, topical and skin care and anti-aging products, and weight-management products that target optimal health and wellness.

Wolf Grade COMING SOON

The wolf is in training. Composite grades vs sector — profitability, health, value, momentum — arrive with the percentile engine. Methodology will be public.

Valuation

P/E
P/S0.08
P/FCF
EV/EBITDA3.67
EV/Sales0.04
Graham №

Profitability

Gross 75.3%
Operating 0.2%
Net -12.0%
FCF -1.4%
ROE / ROIC -832.2% · -64.9%

Financial Health

Current ratio1.09
Quick ratio0.59
Debt / equity-0.50
Debt / EBITDA 2.14
Net cash $4.26M
Working capital$1.73M

Cash Flow · TTM

Operating CF −$469.00K
Capex −$993.00K
Free cash flow −$1.46M
Buybacks
Dividends paid
Shareholder yield

Piotroski F-Score

2 / 9
Weak fundamentals · 2 of 9 signals passing

Altman Z-Score

3.2
Safe zone (> 2.99) · bankruptcy risk negligible

Graham Number vs Price

Requires positive earnings and book value
Fundamentals through 2026-03-31 · computed by TickerWolf from SEC filings